Back to Markets
DFDefinium Therapeutics Inc

Definium Therapeutics Inc

DFTXNASDAQ NMS - GLOBAL MARKET
Health CarePharmaceuticals

$24.19

+0.7100 (+3.02%)

As of 05/29/26 EDT · USD

Compare
Low: $6.35Current: $24.19High: $26.25

Key Statistics

Open

$23.33

Day High

$24.29

Day Low

$23.30

Prev. Close

$23.48

VolumeShares traded today.

2.15M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$2.64B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-9.71

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$26.25

52W LowLowest price over the past 52 weeks.

$6.35

50D MAAverage closing price over the last 50 trading days.

$21.30

200D MAAverage closing price over the last 200 trading days.

$15.29

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.8%

1M

+18.1%

6M

+103.6%

YTD

+77.3%

1Y

+223.4%

About

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.

definiumtx.com/

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade DFTX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.